Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.
Anyone recommend a cheap and reliable level 2 service so can see the order book, how the bid and ask is looking behind the scenes.
Thanks in advance.
To further appreciate this RNS today and the size of the market, recommend reading the great posts from 'hazl' over on another BB (AD VPN)
Distribution Agreement for Quo-Test HbA1c Analyzer
EKF Diagnostics Holdings plc (AIM: EKF), the AIM quoted point-of-care business, announces that it has signed a three-year distribution agreement with Tosoh Europe N.V., part of Tosoh Corporation, the global chemical and specialty materials company, for the distribution of the Company’s Quo-Test HbA1c Analyzer in the Middle East and Africa.
EKF’s Quo-Test is a fully automated desktop HbA1c (glycated hemoglobin) analyzer that provides easy and reliable HbA1c measurement for monitoring and managing diabetes in a Point-of-Care setting, such as diabetes clinics and doctors’ surgeries. The sample results are available within four minutes from a 4 microliter sample taken from a finger prick or venous whole blood. Step by step instructions displayed on the Quo-Test analyzer’s clear, multi-lingual display, reduce staff training time to a minimum, eliminating the opportunity for user-related errors.
The Tosoh Bioscience division is one of the largest global manufacturers of High Performance Liquid Chromatography (HPLC) equipment for glycated hemoglobin analysis, offering scalable solutions predominantly in core laboratories. Tosoh Europe have seen a growing need for Point-of-Care HbA1c analysis alongside their traditional laboratory market and have identified EKF Diagnostics as an important partner to work with them to provide this to their customers. The agreement will allow both EKF and Tosoh Europe to work in markets they have previously been unable to access and provides Tosoh Europe with the opportunity to offer new services to suit changing customer requirements.
After the initial three-year term for the Middle East and Africa, the agreement has a rolling one-year renewal with the option to extend the agreement to into EU countries as required.
Commenting, Julian Baines, CEO of EKF, said: “We are delighted to partner with Tosoh Europe as they expand their need for Point-of-Care analysis in a time where those suffering from diabetes are at greater risk. This new agreement continues to strengthen the position of our core business and gives us the opportunity to move into new territories with a strong partner. We hope to build a successful working partnership with Tosoh Europe and look forward to extending the agreement into additional markets.”
To allow us to buy more of course before everyone else lol
https://www.ekfdiagnostics.com/distribution-agreement-for-quo-test-hba1c-analyzer.html
Bought in at 41.85 today, feel that this is still under the radar, after reading recent results and especially the 2 RNS Covid contracts, that have great potential to expand significantly.
Is this breakout a 52-week high or an all-time high?
If the large seller is finally out, that should release the brakes...
Great research and posts, thanks all.
https://www.google.com/amp/s/www.proactiveinvestors.co.uk/companies/amp/news/917874
a short article about funds and the biotech investment boom
"Synairgen (LON:SNG) is working on a treatment to alleviate the symptoms of severe coronavirus sufferers..."
blue...that will flatten the...nerves lol
look at AVCT and note there SP past week a drop from roughly 71p high to low 52p and then boom today, expect the same here, no share goes up in a straight line remember.
GLA
Coronavirus: what’s happening in the labs of pharma companies worldwide
https://www.proactiveinvestors.co.uk/companies/news/917772/coronavirus-whats-happening-in-the-labs-of-pharma-companies-worldwide-917772.html
i'm going back into hiding now...but sure many more like me that read and rarely post....just before i do, big shout out to so many of you that post valuable information...and definitely worth reading those xxxyyyzzz posts again and again...
GLA and stay safe.
lucky buggers getting in at 35p and doubling their money pretty quickly, no wonder they are "wealthy" individuals lol just letting off a little steam, not directed at anyone.
just got another boost!
on the leaderboard
what would be the realistic range of an offer?
this perked up yesterday afternoon, wonder if there will be any follow through today.
up 10% and on the leaderboard, anyone noticed?
Surely, not priced in...
"Additionally, Mereo will be eligible to receive up to $300 million in future clinical, regulatory and commercial milestones, tiered royalties ranging from the mid-single-digit to sub-teen percentages on global annual net sales of navicixizumab, as well as a negotiated percentage of sublicensing revenues from certain sublicensees."
bloody frustrating lol